Intrinsically disordered proteins lack a fixed structure, which is why they have been considered "undruggable" targets for ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an estrogen independent manner. Targeting vimentin and/or the long ...

Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia. Published in The ...

Scientists have identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia. The study points to a potentially new target for ...

A DGIST research team led by Prof. Yoo Wookyung (Department of Brain Sciences) and Prof. Kim Jin Hae (Department of New Biology) developed an innovative analytical technology in collaboration with a ...

Joint research team of DGIST and KBSI developed precision protein analysis technology to identify causes of intractable diseases - Presented a new analytical horizon for developing treatments for ...

Researchers at Karolinska Institutet have developed a computational method capable of simulating the movements of some of the ...

A new study published in “The EMBO Journal” points to new potential strategies to treat psychiatric and gastrointestinal disorders that are not well addressed by current medications. Dr. Bianca ...